Johnson & Johnson stock heads into the open after a 0.2% gain

At the close on September 15, 2026, Johnson & Johnson stock finished the New York session near USD 266.99, up about 0.2%, after trading between USD 266.22 and USD 271.54 and against a weaker broad US equity market.

Johnson & Johnson stock closed at USD 266.99 on the New York Stock Exchange on September 15, 2026, gaining roughly 0.2% for the session and holding above its recent trading range midpoint per data compiled by Robinhood. The move came as the broader US equity market declined, with major indices such as the Dow Jones Industrial Average and the S&P 500 ending lower on the same day.

September 15, 2026 in numbers

Johnson & Johnson Inc. (ISIN US4781601046, NYSE: JNJ) traded between an intraday low of USD 266.22 and a high of USD 271.54 on September 15, 2026, with volume near 4,740,000 shares versus an average volume of about 6,070,000 shares, according to Robinhood data referenced in an article on ad-hoc-news.de. The same overview put the company’s market capitalization at around USD 641.83 billion as of September 15, 2026, underlining its role as a large-cap healthcare name within the US market. Per that Robinhood-based snapshot, the closing level of USD 266.99 sat within a broader 52-week trading band that remains consistent with a defensive profile in volatile markets.ad-hoc-news.de Market commentary for September 15, 2026 noted that US benchmarks such as the Dow Jones Industrial Average and the S&P 500 fell as rising Treasury yields and higher oil prices pressured risk assets, a backdrop in which Johnson & Johnson’s modest gain stood out against the negative index performance.Sina Finance

Today’s focus around Johnson & Johnson

Earnings calendars and analyst overviews in mid-September 2026 place Johnson & Johnson’s next major scheduled report, its third quarter 2026 earnings, on October 13, 2026, leaving no company specific results or capital markets events due today for the stock.MarketBeat Analyst coverage summarized by MarketBeat continues to frame the shares with a moderate buy consensus and a blended target price above the latest close, which keeps attention on how broader healthcare sentiment and interest rate expectations may guide trading into today’s US session.MarketBeat More broadly, investors in large diversified healthcare names such as Johnson & Johnson are set to track incoming US macro data and movements in Treasury yields and energy prices today, factors highlighted in recent US market wraps as key drivers of equity volatility.Daily US Stock News